Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://doi.org/10.25358/openscience-8337
Autoren: Kayki-Mutlu, Gizem
Aksoyalp, Zinnet Sevval
Wojnowski, Leszek
Michel, Martin C.
Titel: A year in pharmacology : new drugs approved by the US Food and Drug Administration in 2021
Online-Publikationsdatum: 5-Jan-2023
Erscheinungsdatum: 2022
Sprache des Dokuments: Englisch
Zusammenfassung/Abstract: The second year of the COVID-19 pandemic had no adverse effect on the number of new drug approvals by the US Food and Drug Administration (FDA). Quite the contrary, with a total of 50 new drugs, 2021 belongs to the most successful FDA years. We assign these new drugs to one of three levels of innovation: (1) first drug against a condition (“first-in-indication”), (2) first drug using a novel molecular mechanism (“first-in-class”), and (3) “next-in-class”, i.e., a drug using an already exploited molecular mechanism. We identify 21 first-in-class, 28 next-in-class, and only one first-in-indication drugs. By treatment area, the largest group is once again cancer drugs, many of which target specific genetic alterations. Every second drug approved in 2021 targets an orphan disease, half of them being cancers. Small molecules continue to dominate new drug approvals, followed by antibodies and non-antibody biopharmaceuticals. In 2021, the FDA continued to approve drugs without strong evidence of clinical effects, best exemplified by the aducanumab controversy.
DDC-Sachgruppe: 610 Medizin
610 Medical sciences
Veröffentlichende Institution: Johannes Gutenberg-Universität Mainz
Organisationseinheit: FB 04 Medizin
Veröffentlichungsort: Mainz
ROR: https://ror.org/023b0x485
DOI: http://doi.org/10.25358/openscience-8337
Version: Published version
Publikationstyp: Zeitschriftenaufsatz
Nutzungsrechte: CC BY
Informationen zu den Nutzungsrechten: https://creativecommons.org/licenses/by/4.0/
Zeitschrift: Naunyn-Schmiedeberg's archives of pharmacology
395
Seitenzahl oder Artikelnummer: 867
885
Verlag: Springer
Verlagsort: Berlin u.a.
Erscheinungsdatum: 2022
ISSN: 1432-1912
DOI der Originalveröffentlichung: 10.1007/s00210-022-02250-2
Enthalten in den Sammlungen:DFG-491381577-H

Dateien zu dieser Ressource:
  Datei Beschreibung GrößeFormat
Miniaturbild
a_year_in_pharmacology__new_d-20221117155652490.pdf1.04 MBAdobe PDFÖffnen/Anzeigen